- Home
- SVRE vs TTNP Comparison
SVRE vs TTNP Comparison
Compare SVRE & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- TTNP
- Stock Information
- Founded
- SVRE 2014
- TTNP 1991
- Country
- SVRE Israel
- TTNP United States
- Employees
- SVRE N/A
- TTNP N/A
- Industry
- SVRE
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SVRE
- TTNP Health Care
- Exchange
- SVRE Nasdaq
- TTNP Nasdaq
- Market Cap
- SVRE 2.8M
- TTNP 3.0M
- IPO Year
- SVRE 2022
- TTNP 1996
- Fundamental
- Price
- SVRE $0.88
- TTNP $3.79
- Analyst Decision
- SVRE
- TTNP
- Analyst Count
- SVRE 0
- TTNP 0
- Target Price
- SVRE N/A
- TTNP N/A
- AVG Volume (30 Days)
- SVRE 644.4K
- TTNP 41.9K
- Earning Date
- SVRE 08-27-2024
- TTNP 01-03-2025
- Dividend Yield
- SVRE N/A
- TTNP N/A
- EPS Growth
- SVRE N/A
- TTNP N/A
- EPS
- SVRE N/A
- TTNP N/A
- Revenue
- SVRE $458,952.00
- TTNP N/A
- Revenue This Year
- SVRE N/A
- TTNP N/A
- Revenue Next Year
- SVRE $422.52
- TTNP N/A
- P/E Ratio
- SVRE N/A
- TTNP N/A
- Revenue Growth
- SVRE N/A
- TTNP N/A
- 52 Week Low
- SVRE $0.80
- TTNP $3.03
- 52 Week High
- SVRE $27.00
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- SVRE 42.74
- TTNP 48.54
- Support Level
- SVRE $0.80
- TTNP $3.14
- Resistance Level
- SVRE $0.94
- TTNP $3.38
- Average True Range (ATR)
- SVRE 0.10
- TTNP 0.22
- MACD
- SVRE 0.00
- TTNP 0.02
- Stochastic Oscillator
- SVRE 15.23
- TTNP 52.24
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.